Phototherapy For Treatment Of Raynaud's Phenomenon

首次发布于 2021 年 5 月 24 日

Botulinum Toxin in Raynaud's Phenomenon

计划入组 24 人 · 首次发布于 2021 年 11 月 18 日

Dermoscopy in Primary Raynaud's Phenomenon

计划入组 100 人 · 首次发布于 2020 年 11 月 25 日

Isoxsuprine

C₁₈H₂₃NO₃

COX-2 inhibitors (Phenomenome)

Raynaud syndrome(Tritech Bio)

Liquidia's YUTREPIA Receives FDA Fast Track Designation for Systemic Sclerosis-Associated Raynaud's Phenomenon

Aisa Pharma's AISA-021 Shows Promise in Phase 2 Trial for Systemic Sclerosis-Associated Raynaud's Phenomenon

Liquidia Reports Strong YUTREPIA Launch with $148.3M in Full-Year 2025 Sales, Expands Clinical Pipeline